Changes in caveolin-1 expression and vasoreactivity in the aorta and corpus cavernosum of fructose and streptozotocin-induced diabetic rats

European Journal of Pharmacology

Volumn 642, Issue 1-3, 2010, Pages 113-120

  Elçioǧlu, Kübra H ^a   Kabasakal, Levent ^a   Çetinel, Şule ^a   Conturk, Gazi ^a   Sezen, Sena F ^b   Ayanoǧlu Dülger, Gül ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Aorta; Caveolin 1; Corpus cavernosum; Diabetes; Fructose

Indexed keywords

ACETYLCHOLINE; CAVEOLIN 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FRUCTOSE; INSULIN; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; GLUCOSE BLOOD LEVEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BODY WEIGHT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS CAVERNOSUM; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE CONTRACTILITY; STREPTOZOCIN DIABETES; ANIMAL; BLOOD; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PENIS; VASCULARIZATION; VASOCONSTRICTION; WESTERN BLOTTING; WISTAR RAT;

ANIMALS; AORTA; BLOOD GLUCOSE; BLOTTING, WESTERN; BODY WEIGHT; CAVEOLIN 1; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FRUCTOSE; GENE EXPRESSION REGULATION; INSULIN; MALE; PENIS; RATS; RATS, WISTAR; VASOCONSTRICTION;

EID: 77954689257     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.05.049     Document Type: Article

References (60)

1. Agrawal D.K., Mcnei{dotless}ll J.H. The effect of diabetes on vascular smooth muscle function in normotensive and spontaneously hypertensive rat artery. Can. J. Physiol. Pharmacol. 1987, 65:2274-2280.
2. Anderson R.G.W. The caveolae membrane system. Annu. Rev. Biochem. 1998, 67:199-225.
3. Bacon C.G., Hu F.B., Giovannucci E. Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. Diab. Care 2002, 25:1458-1463.
4. Bakircioglu M.E., Sievert K.D., Nunes L., Lau A., Lin C.S., Lue T.F. Decreased trabecular smooth muscle and caveolin-1 expression in the penile tissue of aged rats. J. Urol. 2001, 166:734-738.
5. Baki{dotless}rci{dotless}oǧlu M.E., Kenneth H., El-Sakka A., Si{dotless}evert K.D., Li{dotless}n C.S., Lue T.F. Effect of a chinese herbal medicine mixture on a rat model of hypercholesterolemic erectile dysfunction. J. Urol. 2000, 164:1798-1801.
6. Baron A.D., Clark M.G. Role of blood flow in the regulation of muscle glucose uptake. Annu. Rev. Nutr. 1997, 17:487-499.
7. Bitar M.S., Wahid S., Mustafa S., Al-Saleh E., Dhaunsi G.S., Al-Mulla F. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes. Eur. J. Pharmacol. 2005, 511:53-64.
8. Bucci M., Roviezzo F., Brancaelone V., Lin M.I., Lorenzo A.D., Cicala C., Pinto A., Sessa W.C., Farneti S., Fiorucci S., Cirino G. Diabetic mouse angiopathy is linked to progressive sympathetic receptor deletion coupled to an enhanced caveolin-1 expression. Arterioscler. Thromb. Vasc. Biol. 2004, 24:721-726.
9. Chang K.S.K., Stevens W.C. Endothelium-dependent increase in vascular sensitivity to phenylephrine in long-term streptozotocin diabetic rat aorta. Br. J. Pharmacol. 1992, 107:983-990.
10. Cohen R.A., Tesfamari{dotless}um B., Wei{dotless}sbrod R.M., Zi{dotless}tnay K.M. Adrenergic denervation in rabbits with diabetes mellitus. Am. J. Physiol. 1990, 259:H55-H61.
11. De Vri{dotless}ese A.S., Verbeuren T.J., Van De Voorde J., Lamei{dotless}re N.H., Vanhoutte P.M. Endothelial dysfunction in diabetes. Br. J. Pharmacol. 2000, 130:963-974.
12. Dhillon B., Badiwala M.V., Li S.H., Li R.K., Weisel R.D., Mickle D.A.G., Fedak P.W.M., Rao V., Verma S. Caveolin: a key target for modulating nitric oxide availability in health and disease. Mol. Cell. Biochem. 2003, 247:101-109.
13. Feron O., Saldana F., Michel J.B., Michel T. The endothelial nitric-oxide synthase-caveolin regulatory cycle. J. Biol. Chem. 1998, 273:3125-3128.
14. Fielding P.E., Fielding C.J. Plasma membrane caveolae mediate the efflux of cellular free cholesterol. Biochem 1995, 34:14288-14292.
15. Figueroa X.F., Gonzalez D.R., Martinez A.D., Duran W.N., Boric M.P. Ach-induced endothelial NO synthase translocation, NO release and vasodilatation in the hamster microcirculation in vivo. J. Physiol. 2002, 544:883-896.
16. Fulton D.J.R., Hodgson W.C., Si{dotless}korski{dotless} B.W., Ki{dotless}ng R.G. Attenuated responses to endothelin-1, KCl and CaCl2, but not noradrenaline, or aortae from rats with streptozotocin-induced diabetes mellitus. Br. J. Pharmacol. 1991, 104:928-932.
17. Glenny J.R. The sequence of human caveolin reveals identity with VIP21, a component of transport vesicles. FEBS Lett. 1992, 314:45-48.
18. Han S.Z., Oi{dotless}chi{dotless} Y., Karaki{dotless} H., Ori{dotless}mo H. Inhibitory e€ects of insulin on cytosolic Ca2+ levels and contraction in the rat aorta: endothelium-dependent and -independent mechanisms. Circ. Res. 1995, 77:673-678.
19. Hayashi T., Juliet P.A.R., Kano-Hayashi H., Tsunekawa T., Dingqunfang D., Sumi D., Matsui-Hirai H., Fukatsu A., Iguchi A. NADPH oxidase inhibitor, apocynin, restores the impaired endothelial-dependent and -independent responses and scavenges superoxide anion in rats with type 2 diabetes complicated by NO dysfunction. Diabet. Obes. Metabol. 2005, 7:334-343.
20. Head R.J., Longhurst P.A., Panek R.L., Sti{dotless}tzel R.E. A contrasting effect of the diabetic state upon the contractile responses of aortic preparations from the rat and rabbit. Br. J. Pharmacol. 1987, 91:275-287.
21. Hecht M.J., Neundorfer B., Kiesewetter F. Neuropathy is a major contributing factor to diabetic erectile dysfunction. Neurol. Res. 2001, 23:651-654.
22. Herman W.H., Sinnock P., Brenner E. An epidemiologic model for diabetes mellitus: incidence, prevalence, and mortality. Diab. Care 1984, 7:367-371.
23. Heygate K.M., Davies J., Holmes M., James R.F.L., Thurston H. The effect of insulin treatment and of islet transplantation on the resistance artery function in the STZ-induced diabetic rat. Br. J. Pharmacol. 1996, 19:495-504.
24. James G.M., Hodgson W.C., Davi{dotless}es E.A., Haynes J.M. Attenuated 5-hydroxytryptamine receptor-mediated re-sponses in aortae from streptozotocin-induced diabetic rats. Br. J. Pharmacol. 1994, 111:370-376.
25. Ju H., Zou R., Venema V.J., Venema R.C. Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity. J. Biol. Chem. 1997, 272:18522-18525.
26. Kamata K., Mi{dotless}yata N., Kasuya Y. Impairment of endothelium-dependent relaxation and changes in levels of cyclic GMP in aorta from streptozotocin-induced diabetic rats. Br. J. Pharmacol. 1989, 97:614-618.
27. Kobayashi T., Kamata K. Effect of insulin treatment on smooth muscle contractility and endothelium-dependent relaxation in rat aortae from established STZ-induced diabetes. Br. J. Pharmacol. 1999, 127:835-842.
28. Lam T.Y., Seto S.W., Lau Y.M., Au L.S., Kwan Y.W., Ngai S.M., Tsui K.W. Impairment of the vascular relaxation and differential expression of caveolin-1 of the aorta of diabetic+db/+db mice. Eur. J. Pharmacol. 2006, 546:134-141.
29. 2-adrenergic vasorelaxation by a pertussis toxin mechanism. Hypertension 1997, 30:1128-1134.
30. Linder A.E., McCluskey L.P., Cole K.R., Lanning K.M. Dynamic association of nitric oxide downstream signaling molecules with endothelial caveolin-1 in rat aorta. J. Pharm. Exp. Therap. 2005, 314:9-15.
31. Linder A.E., Leite R., Lauria K., Mills T.M., Webb R.C. Penile erection requires association of soluble guanylyl cyclase with endothelial caveolin-1 in rat corpus cavernosum. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 290:R1302-R1308.
32. Macleod K.M. The effect of insulin treatment on changes in vascular reactivity in chronic, experimental diabetes. Diabetes 1985, 34:1160-1167.
33. Mi{dotless}atello R., Vazquez M., Renna N., Cruazodom M., Zumino A.P., Ri{dotless}sler N. Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructose-fed rats. Am. J. Hypertens. 2005, 18:864-870.
34. Mulhern M., Docherty J.R. Effects of experimental diabetes on the responsiveness of the rat aorta. Br. J. Pharmacol. 1989, 97:1007-1012.
35. Nyby M.D., Matsumoto K., Yamamoto K., Abedi K., Eslam{dotless} P., Hernandez G., Smutko V., Berger M.E., Tuck M.L. Dietary fish oil prevents vascular dysfunction and oxidative stress in hyperinsulinemic rats. Am. J. Hypertens. 2005, 18:213-219.
36. Oudot A., Behr-Roussel D., Compagn{dotless}e S., Ca{dotless}sey S., Le Coz O., Gorny D., Alexandre L., G{dotless}ul{dotless}ano F. Endothelial dysfunction in insulinresistant rats is associated with oxidative stressand COX pathway dysregulation. Physiol. Res. 2009, 58:499-509.
37. Oyama Y., Kawasak{dotless} H., Hattor{dotless} Y., Kanno M. Attenuation of endothelium-dependent relaxation in aorta from diabetic rats. Eur. J. Pharmacol. 1986, 132:75-78.
38. Park C.S., Ryu S.D., Hwang S.Y. Elevation of intracavernous pressure and NO-cGMP activity by a new herbal formula in penile tissues of aged and diabetic rats. J. Ethnopharmacol. 2004, 94:85-92.
39. Paskaloglu K.,Şener G., Ayanolu-Dülger D. Melatonin treatment protects against diabetes-induced functional and biochemical changes in rat aorta and corpus cavernosum. Eur. J. Pharmacol. 2004, 499:345-354.
40. Pfaffman M.A., Ball C.R., Darby A., Hi{dotless}lman R. Insulin reversal of diabetes-induced inhibition of vascular contractility in the rat. Am. J. Physiol. 1982, 242:H490-H495.
41. Pieper G.M. Divergent actions of chronic insulin treatment in vivo versus acute treatment ex vivo on diabetic-induced endothelial dysfunction. Life Sci. 1997, 60:PL371-PL376.
42. Pieper G.M., Gross G.J. Oxygen free radical abolish endothelium-dependent relaxation in diabetic rat aorta. Am. J. Physiol. 1988, 255:H825-H833.
43. Predescu D., Predescu S., McQuistan T., Palade G.E. Transcytosis of α1-acidic glycoprotein in the continuous microvascular endothelium. Proc. Natl Acad. Sci. USA 1998, 95:6175-6180.
44. Rajfer J., Aronson W.J., Bush P.A., Dorey F.J., Ignarro L.J. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J. Med. 1992, 326:90-94.
45. Romeo J.H., Seftel A.D., Madhun Z.T. Sexual function in men with diabetes type 2: association with glycemic control. J. Urol. 2000, 163:788-791.
46. Sasaki K., Yoshimura N., Chancellor M.B. Implications of diabetes mellitus in urology. Urol. Clin. N. Am. 2003, 30:1-12.
47. Segal S.S., Brett S.E., Sessa W.C. Codistribution of NOS and caveolin throughout peripheral vasculature and skeletal muscle of hamsters. Am. J. Physiol. 1999, 277:H1167-H1177.
48. Shakirova Y., Hedlund P., Sward K. Impaired nerve-mediated relaxation of penile tissue from caveolin-1 deficient mice. Eur. J. Pharmacol. 2009, 602:399-405.
49. Shaul P.W., Anderson R.G. Role of plasmalemmal caveolae in signal transduction. Am. J. Pysiol. 1998, 275:L843-L851.
50. Shi{dotless}nozaki K., Ni{dotless}shi{dotless}o Y., Okamura T., Yoshi{dotless}da Y., Maegawa H., Koji{dotless}ma H., Masada M., Toda N., Ki{dotless}kkawa R., Kashi{dotless}wagi{dotless}a A. Oral administration of tetrahydrobiopterin prevents endothelial dysfunction and vascular oxidative stress in the aortas of insulin-resistant rats. Circ. Res. 2000, 87:566-573.
51. Tack C.J.J., Lutterman J.A., Vervoort G., Thi{dotless}en T., Smi{dotless}ts P. Activation of the sodium-potassium pump contributes to insulin-induced vasodilation in humans. Hypertension 1996, 28:426-432.
52. Taylor P.D., Wi{dotless}ckenden A.D., Mi{dotless}rrlees D.J., Poston L. Endothelial function in the isolated perfused mesentery and aortae of rats with streptozotocin-induced diabetes: effect of treatment with the aldose reductase inhibitor ponalrestat. Br. J. Pharmacol. 1994, 111:42-48.
53. Taylor P.D., Graves J.E., Poston L. Selective impairment of acetylcholine-mediated endothelium-dependent relaxation in isolated resistance arteries of the streptozotocin induced diabetic rat. Clin. Sci. 1995, 88:519-524.
54. Vinik A.L., Mehrabyan A. Diabetic Neuropathies. Med. Clin. North Am. 2004, 88(4):947-999.
55. Whi{dotless}te R.E., Carri{dotless}er G.O. Enhanced vascular adrenergic neuroeffector system in diabetics: importance of calcium. Am. J. Physiol. 1988, 255:H1036-H1042.
56. Wu H., Jeng Y.Y., Yue C., Chyu K.Y., Hsueh W.A., Chanhan T.M. Endothelial-dependent vascular effects of insulin and insulin-like growth factor I in the perfused rat mesenteric artery and aortic ring. Diabetes 1994, 43:1027-1032.
57. Yagi{dotless} S., Takata S., Ki{dotless}yokawa H., Yamamoto M., Noto Y., Ikeda T., HattoriI N. Effects of insulin on vasoconstrictive responses to norepinephrine and angiotensin II in rabbit and femoral artery and vein. Diabetes 1988, 37:1064-1069.
58. Yakagawa Y., Merger M.E., Hori M.T., Tuck M.L., Golub M.S. Long-term fructose feeding impairs vascular relaxation in rat mesenteric arteries. Am. J. Hypertens. 2001, 14:811-817.
59. Young M.E., Leighton B. Evidence for altered sensitivity of the nitric oxide/cGMP signalling cascade in insulin-resistant skeletal muscle. Biochem. J. 1998, 329:73-79.
60. Zimmet P., Alberti K.G., Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001, 414:782-787.